European Court Adviser Backs €53M AstraZeneca Antitrust Fine
A European Union court has correctly fined AstraZeneca PLC €52.5 million ($62 million) for abusing its market dominance and the European patent system in order to block generic versions of ulcer...To view the full article, register now.
Already a subscriber? Click here to view full article